← Leaderboards
Sven M Karlsson
Stellular Bio, Inc.
$1,508,750
Attributed
$1,508,750
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $779.4K · FY2016–17$1M$750K$500K$250K$0
'16
'17
Funding mix
By agency
NIH$1,508,750 · 2
By mechanism
R44$1,458,750 · 1
SB1$50,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Stellular Bio, Inc.
Same institution · by research overlap
- Dean Alan Falb$2,022,100
- Bradford Dykstra$1,308,585
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthHemorrhageCoagulation ProcessFundingCollectionHalf-LifeAdultBiogenesisEquipment And Supply InventoriesFreezingBioreactorsBirthBloodBlood CirculationBlood PlateletsAmericanBlood VesselsBone MarrowArchitectureDrug KineticsCancer TherapyClinical TrialsCell Culture TechniquesHour
Grant awards (3)
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function$729,375
R44 · FY2017 · HL · contact PI
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function$729,375
R44 · FY2016 · HL · contact PI
Development of an intellectual property (IP) strategy for the commercial advancement of a Direct Phase II SBIR-funded human platelet bioreactor$50,000
SB1 · FY2016 · HL · contact PI